Zhdx Sindh High Court asks LEAs to file comments on missing persons; whereabouts
BANGALORE, INDIA:Uber and its Indian rival Ola on Thursday launched pilot taxi motorbike services within hours of each other, as competition between the two taxi apps ramps up.Both start-ups are trialling the motorbike taxis in the traffic-clogged southern city of Bangalore, seeking to grab a greater share of India's ultra-competitive ride-hailing market.Pakistani en adidas samba vegan trepreneurs launch 鈥楿ber for rickshaws鈥橳he American firm's UberMOTO will start at 15 rupees (22 US cents) per ride while Ola's Bike Taxis will start at 30 rupees, but have a lower fare per kilometre."This will help users get to where they want to be within minutes, especially in tr adidas campus pink affic-prone cities like ours," said Pranay Jivrajka, chief operating officer of Ola, India's biggest taxi-hailing app.Ola plans to scale up the service in the city in the coming weeks, he said.Ride-hailing apps have risen rapidly to become a samba og adidas multi-billion-dollar industry in India's congested cities, but have faced controversy over safety.An Uber d Spinifex Pharmaceuticals has announced that it has appointed Dr Ronald Marcus as Chief Medical Officer. Dr Marcus will be responsible for driving the development of Spinifex鈥檚 lead candidate EMA401 and the Company鈥檚 pre-clinical pipeline. He takes up his position immediately.EMA401 is dunk low a novel a nike dunk sb ngiotensin II type 2 (AT2) receptor antagonist being developed as a potential first-in-class oral treatment for chronic pain without CNS side-effects. Current treatments for chronic pain do not relieve pain in all individuals and so drugs targeting a new approach to pain treatment are needed.Dr Marcus has more than 20 years鈥?pharmaceutical clinical development experience. He joins Spinifex after a successful career at Bristol-Myers Squibb (BMS), having held a number of senior leadership positions within BMS鈥檚 Neuroscience division.Dr Marcus was most recently Executive Director, Neuroscience Global Clinical Research at BMS. In this role he was Early Development Team jordan2 Leader for neuropathic pain, sc |
